Net Cash Provided by (Used in) Operating Activities |
-146K |
USD |
+13% |
Sep 30, 2023 |
Q3 2023 |
Net Cash Provided by (Used in) Financing Activities |
166K |
USD |
+214% |
Sep 30, 2023 |
Q3 2023 |
Common Stock, Shares Authorized |
1B |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
126M |
shares |
+1614% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
11.8K |
USD |
-87.5% |
Jun 30, 2022 |
Q2 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
8.25K |
USD |
-82.4% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
9.54K |
USD |
|
Sep 30, 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
7.77M |
USD |
+7.22% |
Jun 30, 2022 |
Q2 2022 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
-4.61% |
Jun 30, 2023 |
Q2 2023 |
Deferred Tax Assets, Gross |
8.12M |
USD |
+4.52% |
Jun 30, 2023 |
Q2 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
8.12M |
USD |
+4.52% |
Jun 30, 2023 |
Q2 2023 |
Additional Paid in Capital |
57.8M |
USD |
+5.58% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Jun 30, 2023 |
Q2 2023 |
Share-based Payment Arrangement, Expense |
0 |
USD |
|
Sep 30, 2023 |
Q3 2023 |
Interest Expense |
401K |
USD |
+18.6% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Sep 30, 2022 |
Q3 2022 |